Vidarbha News

Molluscum Contagiosum Market Size and Trends Analysis, Clinical and Commercial Assessment of the Pipeline Therapies, Leading Companies, and Epidemiology Forecast

 Breaking News
  • No posts were found

Molluscum Contagiosum Market Size and Trends Analysis, Clinical and Commercial Assessment of the Pipeline Therapies, Leading Companies, and Epidemiology Forecast

August 02
20:38 2021
Molluscum Contagiosum Market Size and Trends Analysis, Clinical and Commercial Assessment of the Pipeline Therapies, Leading Companies, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Molluscum Contagiosum Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Molluscum Contagiosum Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Molluscum Contagiosum Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Molluscum Contagiosum market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Molluscum Contagiosum treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Molluscum Contagiosum Market


Molluscum contagiosum (MC) is a common skin condition, caused by a member of the poxvirus (molluscum contagiosum virus) family that causes considerable parental anxiety and results in primary and secondary care consultations.

It is a mild skin disease characterized by lesions that may appear anywhere on the body consisting of single or, more often, multiple, rounded, dome-shaped, pink, waxy papules that are 2–5 mm in diameter. People with weakened immune systems are at higher risk for getting MC.

 Molluscum Contagiosum Market Key Facts

  • As per the study conducted by Sunetra et al. (2017), Molluscum Contagiosum infections are common worldwide and approximately 122 million cases occurred in 2010.

  • As per Eichenfield et al. (2005), the occurrence of MC lesions was common in trunk anatomic location in comparison to Extremities and face in the United States.

  • According to the study conducted in the UK titled “Time to resolution and effect on the quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study” by Francis et al. (2015) stated that Molluscum contagiosum has the greatest incidence in individuals aged 1–14 years.

  • A study by Dohil et al. (2006) observed that in pediatric patients most of the cases were of 0–36 months of age followed by 61–96, 37–60, and more than 96 months of age.

Key Benefits of Molluscum Contagiosum Market Report

  • The market report provides an in-depth analysis of Molluscum Contagiosum Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Molluscum Contagiosum Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers the Molluscum Contagiosum current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Molluscum Contagiosum market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Molluscum Contagiosum Market 

Molluscum Contagiosum (MC) Market Size is expected to increase during the forecast period owing to the launch of upcoming therapies.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Molluscum Contagiosum market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Molluscum Contagiosum market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request for Sample @ Molluscum Contagiosum Therapeutics Market Assessment

Molluscum Contagiosum Epidemiology

The epidemiology section covers insights about the historical and current Molluscum Contagiosum patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Molluscum Contagiosum Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Molluscum Contagiosum market or expected to get launched in the market during the study period. The analysis covers Molluscum Contagiosum market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Molluscum Contagiosum Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Several emerging therapies for the treatment of Molluscum contagiosum (MC) are in different stages of clinical development.

Molluscum Contagiosum (MC) Therapies covered in the report include:

  • Novan

  • Veloce BioPharma

  • Ligand Pharmaceuticals

  • Verrica Pharmaceuticals

And many others 

Molluscum Contagiosum (MC) Companies:



And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Molluscum Contagiosum Competitive Intelligence Analysis

4. Molluscum Contagiosum Market Overview at a Glance

5. Molluscum Contagiosum Disease Background and Overview

6. Molluscum Contagiosum Patient Journey

7. Molluscum Contagiosum Epidemiology and Patient Population

8. Molluscum Contagiosum Treatment Algorithm, Current Treatment, and Medical Practices

9. Molluscum Contagiosum Unmet Needs

10. Key Endpoints of Molluscum Contagiosum Treatment

11. Molluscum Contagiosum Marketed Products

12. Molluscum Contagiosum Emerging Therapies

13. Molluscum Contagiosum Seven Major Market Analysis

14. Attribute Analysis

15. Molluscum Contagiosum Market Outlook (7 major markets)

16. Molluscum Contagiosum Access and Reimbursement Overview

17. KOL Views on the Molluscum Contagiosum Market.

18. Molluscum Contagiosum Market Drivers

19. Molluscum Contagiosum Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight

Molluscum Contagiosum Pipeline Insight

Molluscum Contagiosum Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Molluscum Contagiosum (MC) Market.

Healthcare Blogs

Crohn’s Disease Market

Crohn’s disease market is expected to expand owing to the continuous research and developments activities and innovation in drug delivery platforms, MoAs, and RoAs. Globally, some of the key pharmaceutical companies such as Eli Lilly, RedHill Biopharma Ltd., AbbVie, and Boehringer Ingelheim, Gilead Sciences, Galapagos, Celgene, Janssen Pharmaceutical, and several others are developing novel therapies to combat the unmet needs prevailing in the Crohn’s disease therapeutics space include

Pharmaceutical Companies in Musculoskeletal Disorders Market

To reduce the growing burden of Musculoskeletal Disorders, some of the leading companies such as Braeburn Pharmaceuticals, Camurus, Regeneron Pharmaceuticals, Teva Pharmaceutical, Eli Lilly and Company, Mesoblast, Egalet Corporation, Axsome Therapeutics, Allodynic Therapeutics, Astellas Pharma, Grünenthal GmbH, Frontier Biotechnologies, DiscGenics, Semnur Pharmaceuticals, Stayble Therapeutics, AnGes MG, Novartis, Bristol-Myers Squibb, and several others are actively involved in the development of innovative products.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States